Abstract
Cell therapy is a branch of immunotherapy that has been growing in recent decades and shows to be a promising strategy to treat tumors. The fastest growing modality in recent years is therapy based on T cells expressing Chimeric Antigen Receptor (CAR-T). Six products of CAR-T have been approved by the FDA (Food and Drug Administration, USA), all for hematological tumors. Despite the succe…